Spire Healthcare Group (LON:SPI) Trading Up 17.3% – Still a Buy?

Spire Healthcare Group plc (LON:SPI) was up 17.3% during trading on Friday . The stock traded as high as GBX 254.50 ($3.43) and last traded at GBX 253.95 ($3.42). Approximately 38,765,020 shares were traded during trading, an increase of 2,280% from the average daily volume of 1,628,513 shares. The stock had previously closed at GBX 216.50 ($2.92).

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Berenberg Bank reissued a “buy” rating and issued a GBX 280 target price on shares of Spire Healthcare Group in a research note on Thursday, July 31st. JPMorgan Chase & Co. decreased their price target on Spire Healthcare Group from GBX 309 to GBX 303 and set an “overweight” rating for the company in a report on Tuesday, August 5th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of GBX 294.33.

Spire Healthcare Group Stock Performance

The company has a market cap of £993.86 million, a P/E ratio of 5,369.57, a PEG ratio of 1.06 and a beta of 0.96. The company has a 50 day moving average price of GBX 218.75 and a 200-day moving average price of GBX 203.41. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25.

Spire Healthcare Group (LON:SPI) last announced its earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. Equities analysts expect that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.